Medical and Pharmaceutical Supernus Pharmaceuticals picks up embattled Sage Therapeutics Acquiring Sage expands Supernus’s presence in nonpsychiatric conditions Joseph MortonJune 16, 2025
Sleep CND Life Sciences receives NIH grant to study rare sleep disorder The disease tends to show itself years before patients are diagnosed with more serious conditions Rowan DunneOctober 7, 2022